Review



sir actin  (Spirochrome)


Bioz Verified Symbol Spirochrome is a verified supplier
Bioz Manufacturer Symbol Spirochrome manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 98

    Structured Review

    Spirochrome sir actin
    Spectrin determines junctional actomyosin network structure and stability. (a) Newborn epidermal whole-mount immunofluorescence analysis for phalloidin (F-actin) and non-muscle myosin heavy chain IIa (myosin-IIa). Minimal max. projections of the denoted layers are shown. (b) Dorsal skin sections from E17.5 wild-type embryos treated with DMSO or Y27632 (40 µM) immunolabeled for αII-spectrin. (c) Quantification of basal (left graph) and suprabasal (right graph) layer αII-spectrin intensity from data shown in b. Data are the mean ± SD of 30 ROI from n = 3 embryos per condition. Bars: mean normalized intensity; dots: microscopy fields. *P ≤ 0.05; NS: P = 0.3876 with Kolmogorov–Smirnov. (d) Immunofluorescence analysis for αII-spectrin, F-actin, and non-muscle myosin heavy chain IIa (myosin-IIa) (48 h high Ca 2+ ) in Ctr and αII-spectrin–deficient (KO) cells. (e) Immunofluorescence analysis for αII-spectrin and F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown and treatment with either DMSO or low-dose blebbistatin (5 µM). Representative images of n = 3 biological replicates each. (f) Immunofluorescence analysis for F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown at low tension (low-dose blebbistatin 5 µM) showing streak-like defects similar to in vivo. Representative images of n = 3 biological replicates each. (g) Illustration of laser ablation in multilayered keratinocytes. (h) Laser ablation: Still images from live imaging <t>of</t> <t>SiR-actin</t> (F-actin)-labeled Ctr cells (48 h high Ca 2+ ) at indicated time points after 17 µm line ablation showing progressive elliptical cortical openings. (i) Quantification of the elliptical opening area (red line) i.e., recoil over time. Line: mean ± SD opening area of 13 ablations from N = 4 biological replicates. (j) Cortical laser ablation: Still images from live imaging of SiR-actin (F-actin)–labeled Ctr (as shown h) and αII-spectrin knockdown keratinocytes at the time point of analysis (60 s after a linear laser cut [yellow line]) after 48 h high Ca 2+ . The opening in the F-actin cortex is seen as black area around the yellow line. (k) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in j. Lines represent means, dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. *P = 0.0215 with Kolmogorov–Smirnov. (l) Laser ablation (as described for j) of αII-spectrin knockdown keratinocytes treated with DMSO or low dose blebbistatin (5 µM) 1 h prior to ablation. (m) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in l. Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. (n) Laser ablation (as described for j) of E-cadherin −/− keratinocytes after 48 h high Ca 2+ . (o) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in N . Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. ROI, region of interest.
    Sir Actin, supplied by Spirochrome, used in various techniques. Bioz Stars score: 98/100, based on 975 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sir actin/product/Spirochrome
    Average 98 stars, based on 975 article reviews
    sir actin - by Bioz Stars, 2026-04
    98/100 stars

    Images

    1) Product Images from "Spectrin coordinates cell shape and signaling essential for epidermal differentiation"

    Article Title: Spectrin coordinates cell shape and signaling essential for epidermal differentiation

    Journal: The Journal of Cell Biology

    doi: 10.1083/jcb.202502071

    Spectrin determines junctional actomyosin network structure and stability. (a) Newborn epidermal whole-mount immunofluorescence analysis for phalloidin (F-actin) and non-muscle myosin heavy chain IIa (myosin-IIa). Minimal max. projections of the denoted layers are shown. (b) Dorsal skin sections from E17.5 wild-type embryos treated with DMSO or Y27632 (40 µM) immunolabeled for αII-spectrin. (c) Quantification of basal (left graph) and suprabasal (right graph) layer αII-spectrin intensity from data shown in b. Data are the mean ± SD of 30 ROI from n = 3 embryos per condition. Bars: mean normalized intensity; dots: microscopy fields. *P ≤ 0.05; NS: P = 0.3876 with Kolmogorov–Smirnov. (d) Immunofluorescence analysis for αII-spectrin, F-actin, and non-muscle myosin heavy chain IIa (myosin-IIa) (48 h high Ca 2+ ) in Ctr and αII-spectrin–deficient (KO) cells. (e) Immunofluorescence analysis for αII-spectrin and F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown and treatment with either DMSO or low-dose blebbistatin (5 µM). Representative images of n = 3 biological replicates each. (f) Immunofluorescence analysis for F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown at low tension (low-dose blebbistatin 5 µM) showing streak-like defects similar to in vivo. Representative images of n = 3 biological replicates each. (g) Illustration of laser ablation in multilayered keratinocytes. (h) Laser ablation: Still images from live imaging of SiR-actin (F-actin)-labeled Ctr cells (48 h high Ca 2+ ) at indicated time points after 17 µm line ablation showing progressive elliptical cortical openings. (i) Quantification of the elliptical opening area (red line) i.e., recoil over time. Line: mean ± SD opening area of 13 ablations from N = 4 biological replicates. (j) Cortical laser ablation: Still images from live imaging of SiR-actin (F-actin)–labeled Ctr (as shown h) and αII-spectrin knockdown keratinocytes at the time point of analysis (60 s after a linear laser cut [yellow line]) after 48 h high Ca 2+ . The opening in the F-actin cortex is seen as black area around the yellow line. (k) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in j. Lines represent means, dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. *P = 0.0215 with Kolmogorov–Smirnov. (l) Laser ablation (as described for j) of αII-spectrin knockdown keratinocytes treated with DMSO or low dose blebbistatin (5 µM) 1 h prior to ablation. (m) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in l. Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. (n) Laser ablation (as described for j) of E-cadherin −/− keratinocytes after 48 h high Ca 2+ . (o) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in N . Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. ROI, region of interest.
    Figure Legend Snippet: Spectrin determines junctional actomyosin network structure and stability. (a) Newborn epidermal whole-mount immunofluorescence analysis for phalloidin (F-actin) and non-muscle myosin heavy chain IIa (myosin-IIa). Minimal max. projections of the denoted layers are shown. (b) Dorsal skin sections from E17.5 wild-type embryos treated with DMSO or Y27632 (40 µM) immunolabeled for αII-spectrin. (c) Quantification of basal (left graph) and suprabasal (right graph) layer αII-spectrin intensity from data shown in b. Data are the mean ± SD of 30 ROI from n = 3 embryos per condition. Bars: mean normalized intensity; dots: microscopy fields. *P ≤ 0.05; NS: P = 0.3876 with Kolmogorov–Smirnov. (d) Immunofluorescence analysis for αII-spectrin, F-actin, and non-muscle myosin heavy chain IIa (myosin-IIa) (48 h high Ca 2+ ) in Ctr and αII-spectrin–deficient (KO) cells. (e) Immunofluorescence analysis for αII-spectrin and F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown and treatment with either DMSO or low-dose blebbistatin (5 µM). Representative images of n = 3 biological replicates each. (f) Immunofluorescence analysis for F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown at low tension (low-dose blebbistatin 5 µM) showing streak-like defects similar to in vivo. Representative images of n = 3 biological replicates each. (g) Illustration of laser ablation in multilayered keratinocytes. (h) Laser ablation: Still images from live imaging of SiR-actin (F-actin)-labeled Ctr cells (48 h high Ca 2+ ) at indicated time points after 17 µm line ablation showing progressive elliptical cortical openings. (i) Quantification of the elliptical opening area (red line) i.e., recoil over time. Line: mean ± SD opening area of 13 ablations from N = 4 biological replicates. (j) Cortical laser ablation: Still images from live imaging of SiR-actin (F-actin)–labeled Ctr (as shown h) and αII-spectrin knockdown keratinocytes at the time point of analysis (60 s after a linear laser cut [yellow line]) after 48 h high Ca 2+ . The opening in the F-actin cortex is seen as black area around the yellow line. (k) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in j. Lines represent means, dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. *P = 0.0215 with Kolmogorov–Smirnov. (l) Laser ablation (as described for j) of αII-spectrin knockdown keratinocytes treated with DMSO or low dose blebbistatin (5 µM) 1 h prior to ablation. (m) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in l. Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. (n) Laser ablation (as described for j) of E-cadherin −/− keratinocytes after 48 h high Ca 2+ . (o) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in N . Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. ROI, region of interest.

    Techniques Used: Immunofluorescence, Immunolabeling, Microscopy, Knockdown, In Vivo, Imaging, Labeling



    Similar Products

    97
    Cytoskeleton Inc sir actin
    Sir Actin, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sir actin/product/Cytoskeleton Inc
    Average 97 stars, based on 1 article reviews
    sir actin - by Bioz Stars, 2026-04
    97/100 stars
      Buy from Supplier

    98
    Spirochrome sir actin
    Spectrin determines junctional actomyosin network structure and stability. (a) Newborn epidermal whole-mount immunofluorescence analysis for phalloidin (F-actin) and non-muscle myosin heavy chain IIa (myosin-IIa). Minimal max. projections of the denoted layers are shown. (b) Dorsal skin sections from E17.5 wild-type embryos treated with DMSO or Y27632 (40 µM) immunolabeled for αII-spectrin. (c) Quantification of basal (left graph) and suprabasal (right graph) layer αII-spectrin intensity from data shown in b. Data are the mean ± SD of 30 ROI from n = 3 embryos per condition. Bars: mean normalized intensity; dots: microscopy fields. *P ≤ 0.05; NS: P = 0.3876 with Kolmogorov–Smirnov. (d) Immunofluorescence analysis for αII-spectrin, F-actin, and non-muscle myosin heavy chain IIa (myosin-IIa) (48 h high Ca 2+ ) in Ctr and αII-spectrin–deficient (KO) cells. (e) Immunofluorescence analysis for αII-spectrin and F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown and treatment with either DMSO or low-dose blebbistatin (5 µM). Representative images of n = 3 biological replicates each. (f) Immunofluorescence analysis for F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown at low tension (low-dose blebbistatin 5 µM) showing streak-like defects similar to in vivo. Representative images of n = 3 biological replicates each. (g) Illustration of laser ablation in multilayered keratinocytes. (h) Laser ablation: Still images from live imaging <t>of</t> <t>SiR-actin</t> (F-actin)-labeled Ctr cells (48 h high Ca 2+ ) at indicated time points after 17 µm line ablation showing progressive elliptical cortical openings. (i) Quantification of the elliptical opening area (red line) i.e., recoil over time. Line: mean ± SD opening area of 13 ablations from N = 4 biological replicates. (j) Cortical laser ablation: Still images from live imaging of SiR-actin (F-actin)–labeled Ctr (as shown h) and αII-spectrin knockdown keratinocytes at the time point of analysis (60 s after a linear laser cut [yellow line]) after 48 h high Ca 2+ . The opening in the F-actin cortex is seen as black area around the yellow line. (k) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in j. Lines represent means, dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. *P = 0.0215 with Kolmogorov–Smirnov. (l) Laser ablation (as described for j) of αII-spectrin knockdown keratinocytes treated with DMSO or low dose blebbistatin (5 µM) 1 h prior to ablation. (m) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in l. Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. (n) Laser ablation (as described for j) of E-cadherin −/− keratinocytes after 48 h high Ca 2+ . (o) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in N . Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. ROI, region of interest.
    Sir Actin, supplied by Spirochrome, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sir actin/product/Spirochrome
    Average 98 stars, based on 1 article reviews
    sir actin - by Bioz Stars, 2026-04
    98/100 stars
      Buy from Supplier

    98
    Spirochrome sir-actin
    Spectrin determines junctional actomyosin network structure and stability. (a) Newborn epidermal whole-mount immunofluorescence analysis for phalloidin (F-actin) and non-muscle myosin heavy chain IIa (myosin-IIa). Minimal max. projections of the denoted layers are shown. (b) Dorsal skin sections from E17.5 wild-type embryos treated with DMSO or Y27632 (40 µM) immunolabeled for αII-spectrin. (c) Quantification of basal (left graph) and suprabasal (right graph) layer αII-spectrin intensity from data shown in b. Data are the mean ± SD of 30 ROI from n = 3 embryos per condition. Bars: mean normalized intensity; dots: microscopy fields. *P ≤ 0.05; NS: P = 0.3876 with Kolmogorov–Smirnov. (d) Immunofluorescence analysis for αII-spectrin, F-actin, and non-muscle myosin heavy chain IIa (myosin-IIa) (48 h high Ca 2+ ) in Ctr and αII-spectrin–deficient (KO) cells. (e) Immunofluorescence analysis for αII-spectrin and F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown and treatment with either DMSO or low-dose blebbistatin (5 µM). Representative images of n = 3 biological replicates each. (f) Immunofluorescence analysis for F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown at low tension (low-dose blebbistatin 5 µM) showing streak-like defects similar to in vivo. Representative images of n = 3 biological replicates each. (g) Illustration of laser ablation in multilayered keratinocytes. (h) Laser ablation: Still images from live imaging <t>of</t> <t>SiR-actin</t> (F-actin)-labeled Ctr cells (48 h high Ca 2+ ) at indicated time points after 17 µm line ablation showing progressive elliptical cortical openings. (i) Quantification of the elliptical opening area (red line) i.e., recoil over time. Line: mean ± SD opening area of 13 ablations from N = 4 biological replicates. (j) Cortical laser ablation: Still images from live imaging of SiR-actin (F-actin)–labeled Ctr (as shown h) and αII-spectrin knockdown keratinocytes at the time point of analysis (60 s after a linear laser cut [yellow line]) after 48 h high Ca 2+ . The opening in the F-actin cortex is seen as black area around the yellow line. (k) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in j. Lines represent means, dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. *P = 0.0215 with Kolmogorov–Smirnov. (l) Laser ablation (as described for j) of αII-spectrin knockdown keratinocytes treated with DMSO or low dose blebbistatin (5 µM) 1 h prior to ablation. (m) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in l. Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. (n) Laser ablation (as described for j) of E-cadherin −/− keratinocytes after 48 h high Ca 2+ . (o) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in N . Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. ROI, region of interest.
    Sir Actin, supplied by Spirochrome, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sir-actin/product/Spirochrome
    Average 98 stars, based on 1 article reviews
    sir-actin - by Bioz Stars, 2026-04
    98/100 stars
      Buy from Supplier

    98
    Spirochrome siractin
    Spectrin determines junctional actomyosin network structure and stability. (a) Newborn epidermal whole-mount immunofluorescence analysis for phalloidin (F-actin) and non-muscle myosin heavy chain IIa (myosin-IIa). Minimal max. projections of the denoted layers are shown. (b) Dorsal skin sections from E17.5 wild-type embryos treated with DMSO or Y27632 (40 µM) immunolabeled for αII-spectrin. (c) Quantification of basal (left graph) and suprabasal (right graph) layer αII-spectrin intensity from data shown in b. Data are the mean ± SD of 30 ROI from n = 3 embryos per condition. Bars: mean normalized intensity; dots: microscopy fields. *P ≤ 0.05; NS: P = 0.3876 with Kolmogorov–Smirnov. (d) Immunofluorescence analysis for αII-spectrin, F-actin, and non-muscle myosin heavy chain IIa (myosin-IIa) (48 h high Ca 2+ ) in Ctr and αII-spectrin–deficient (KO) cells. (e) Immunofluorescence analysis for αII-spectrin and F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown and treatment with either DMSO or low-dose blebbistatin (5 µM). Representative images of n = 3 biological replicates each. (f) Immunofluorescence analysis for F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown at low tension (low-dose blebbistatin 5 µM) showing streak-like defects similar to in vivo. Representative images of n = 3 biological replicates each. (g) Illustration of laser ablation in multilayered keratinocytes. (h) Laser ablation: Still images from live imaging <t>of</t> <t>SiR-actin</t> (F-actin)-labeled Ctr cells (48 h high Ca 2+ ) at indicated time points after 17 µm line ablation showing progressive elliptical cortical openings. (i) Quantification of the elliptical opening area (red line) i.e., recoil over time. Line: mean ± SD opening area of 13 ablations from N = 4 biological replicates. (j) Cortical laser ablation: Still images from live imaging of SiR-actin (F-actin)–labeled Ctr (as shown h) and αII-spectrin knockdown keratinocytes at the time point of analysis (60 s after a linear laser cut [yellow line]) after 48 h high Ca 2+ . The opening in the F-actin cortex is seen as black area around the yellow line. (k) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in j. Lines represent means, dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. *P = 0.0215 with Kolmogorov–Smirnov. (l) Laser ablation (as described for j) of αII-spectrin knockdown keratinocytes treated with DMSO or low dose blebbistatin (5 µM) 1 h prior to ablation. (m) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in l. Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. (n) Laser ablation (as described for j) of E-cadherin −/− keratinocytes after 48 h high Ca 2+ . (o) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in N . Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. ROI, region of interest.
    Siractin, supplied by Spirochrome, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/siractin/product/Spirochrome
    Average 98 stars, based on 1 article reviews
    siractin - by Bioz Stars, 2026-04
    98/100 stars
      Buy from Supplier

    Image Search Results


    Spectrin determines junctional actomyosin network structure and stability. (a) Newborn epidermal whole-mount immunofluorescence analysis for phalloidin (F-actin) and non-muscle myosin heavy chain IIa (myosin-IIa). Minimal max. projections of the denoted layers are shown. (b) Dorsal skin sections from E17.5 wild-type embryos treated with DMSO or Y27632 (40 µM) immunolabeled for αII-spectrin. (c) Quantification of basal (left graph) and suprabasal (right graph) layer αII-spectrin intensity from data shown in b. Data are the mean ± SD of 30 ROI from n = 3 embryos per condition. Bars: mean normalized intensity; dots: microscopy fields. *P ≤ 0.05; NS: P = 0.3876 with Kolmogorov–Smirnov. (d) Immunofluorescence analysis for αII-spectrin, F-actin, and non-muscle myosin heavy chain IIa (myosin-IIa) (48 h high Ca 2+ ) in Ctr and αII-spectrin–deficient (KO) cells. (e) Immunofluorescence analysis for αII-spectrin and F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown and treatment with either DMSO or low-dose blebbistatin (5 µM). Representative images of n = 3 biological replicates each. (f) Immunofluorescence analysis for F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown at low tension (low-dose blebbistatin 5 µM) showing streak-like defects similar to in vivo. Representative images of n = 3 biological replicates each. (g) Illustration of laser ablation in multilayered keratinocytes. (h) Laser ablation: Still images from live imaging of SiR-actin (F-actin)-labeled Ctr cells (48 h high Ca 2+ ) at indicated time points after 17 µm line ablation showing progressive elliptical cortical openings. (i) Quantification of the elliptical opening area (red line) i.e., recoil over time. Line: mean ± SD opening area of 13 ablations from N = 4 biological replicates. (j) Cortical laser ablation: Still images from live imaging of SiR-actin (F-actin)–labeled Ctr (as shown h) and αII-spectrin knockdown keratinocytes at the time point of analysis (60 s after a linear laser cut [yellow line]) after 48 h high Ca 2+ . The opening in the F-actin cortex is seen as black area around the yellow line. (k) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in j. Lines represent means, dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. *P = 0.0215 with Kolmogorov–Smirnov. (l) Laser ablation (as described for j) of αII-spectrin knockdown keratinocytes treated with DMSO or low dose blebbistatin (5 µM) 1 h prior to ablation. (m) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in l. Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. (n) Laser ablation (as described for j) of E-cadherin −/− keratinocytes after 48 h high Ca 2+ . (o) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in N . Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. ROI, region of interest.

    Journal: The Journal of Cell Biology

    Article Title: Spectrin coordinates cell shape and signaling essential for epidermal differentiation

    doi: 10.1083/jcb.202502071

    Figure Lengend Snippet: Spectrin determines junctional actomyosin network structure and stability. (a) Newborn epidermal whole-mount immunofluorescence analysis for phalloidin (F-actin) and non-muscle myosin heavy chain IIa (myosin-IIa). Minimal max. projections of the denoted layers are shown. (b) Dorsal skin sections from E17.5 wild-type embryos treated with DMSO or Y27632 (40 µM) immunolabeled for αII-spectrin. (c) Quantification of basal (left graph) and suprabasal (right graph) layer αII-spectrin intensity from data shown in b. Data are the mean ± SD of 30 ROI from n = 3 embryos per condition. Bars: mean normalized intensity; dots: microscopy fields. *P ≤ 0.05; NS: P = 0.3876 with Kolmogorov–Smirnov. (d) Immunofluorescence analysis for αII-spectrin, F-actin, and non-muscle myosin heavy chain IIa (myosin-IIa) (48 h high Ca 2+ ) in Ctr and αII-spectrin–deficient (KO) cells. (e) Immunofluorescence analysis for αII-spectrin and F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown and treatment with either DMSO or low-dose blebbistatin (5 µM). Representative images of n = 3 biological replicates each. (f) Immunofluorescence analysis for F-actin (48 h high Ca 2+ ) upon αII-spectrin ( Sptan1 ) knockdown at low tension (low-dose blebbistatin 5 µM) showing streak-like defects similar to in vivo. Representative images of n = 3 biological replicates each. (g) Illustration of laser ablation in multilayered keratinocytes. (h) Laser ablation: Still images from live imaging of SiR-actin (F-actin)-labeled Ctr cells (48 h high Ca 2+ ) at indicated time points after 17 µm line ablation showing progressive elliptical cortical openings. (i) Quantification of the elliptical opening area (red line) i.e., recoil over time. Line: mean ± SD opening area of 13 ablations from N = 4 biological replicates. (j) Cortical laser ablation: Still images from live imaging of SiR-actin (F-actin)–labeled Ctr (as shown h) and αII-spectrin knockdown keratinocytes at the time point of analysis (60 s after a linear laser cut [yellow line]) after 48 h high Ca 2+ . The opening in the F-actin cortex is seen as black area around the yellow line. (k) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in j. Lines represent means, dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. *P = 0.0215 with Kolmogorov–Smirnov. (l) Laser ablation (as described for j) of αII-spectrin knockdown keratinocytes treated with DMSO or low dose blebbistatin (5 µM) 1 h prior to ablation. (m) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in l. Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. (n) Laser ablation (as described for j) of E-cadherin −/− keratinocytes after 48 h high Ca 2+ . (o) Quantification of opening areas in the apical F-actin cortex upon linear laser ablation as shown in N . Lines represent means; dots represent single openings/cells pooled from n = 3 independent experiments/biological replicates. ****P < 0.0001 with Kolmogorov–Smirnov. ROI, region of interest.

    Article Snippet: At confluency, the medium was switched to a high Ca 2+ medium for 48 h. 2 h prior to imaging, the medium was changed to a high Ca 2+ medium containing 1 μM SiR-actin (#CY-SC001; Spirochrome).

    Techniques: Immunofluorescence, Immunolabeling, Microscopy, Knockdown, In Vivo, Imaging, Labeling